EQ · Equillium, Inc. · Metrics
Market Cap
$90.04M
Shares
63.41M
Volume · Oct 28
227.36K
Avg daily vol (3M)
579.9K
EQ metrics
71 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.42
Market cap
$90.04M
Price action
20 metricsPrice change (1W)
-1.4%
Price change (30D)
-19.0%
Price change (3M)
-41.4%
Price change (6M)
-33.7%
Price change (YTD)
-12.3%
Price change (1Y)
-0.7%
Trailing year
Price change (5Y)
-76.5%
52-week high
$3.20
52-week low
$0.84
Change from 52-week high
-57.5%
Change from 52-week low
+61.9%
Annualized volatility
105.7%
Annualized volatility (3M)
87.8%
Beta
1.3
RSI (14D)
42.9
Price vs SMA 50
-25.3%
Price vs SMA 200
-34.4%
Avg volume (3M)
591,283
Relative volume
0.6
Average dollar volume
$1.10M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
63.41M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.1×
reciprocal yield 47.7%
P / book
1.5
reciprocal yield 65.0%
FCF yield
-23.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-20.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.7×
reciprocal yield 147.9%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 147.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-05-27
Profitability
9 metricsGross margin
—
Operating margin
-20.1%
Trailing 12 months
Net margin
-19.6%
Gross profit (TTM)
—
Operating profit (TTM)
−$19.30M
Net income (TTM)
−$18.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-52.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$41.09M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+213.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-32.1%
Return on assets
-30.7%
Debt / equity
0.0
Current ratio
23.4
EBITDA (TTM)
−$9.15M
Free cash flow (TTM)
−$20.09M
Quick ratio
23.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$57.16M
Latest balance sheet
Cash & equivalents
$57.16M
Total assets
$58.67M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$19.97M
Capital expenditures (TTM)
$118,000
R&D (TTM)
$8.58M
SG&A (TTM)
—
Stock compensation (TTM)
$3.16M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
60
13F filer change QoQ
+10
Institutional ownership
66.1%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
37.4%
Private-fund adviser ownership
36.8%
Active holders' share change QoQ
+1.8%
Holder tenure
4.0
Price vs estimated holder cost
+107.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
3.5%
Short interest
3 metricsShort interest
8.9%
Latest settlement · 11.0 days to cover
Days to cover
11.0d
Short-squeeze score
68 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—